Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
600222 Henan Taloph Pharmaceutical Stock
8.220
-0.240-2.84%
YOY
Do not show
Hide blank lines
(Q9)2022/09/30(Q6)2022/06/30(Q3)2022/03/31(FY)2021/12/31
Total operating revenue
16.05% 1.3B 14.87% 863.68M 1.52% 422.28M 13.23% 1.6B
Operating revenue
16.05% 1.3B 14.87% 863.68M 1.52% 422.28M 13.23% 1.6B
Total operating cost
22.04% 1.33B 19.78% 867.32M 8.93% 411.8M 10.37% 1.54B
Operating cost
24.59% 997.44M 20.91% 652.54M 0.53% 293.25M 9.52% 1.14B
Operating tax surcharges
2.17% 5.41M 11.33% 4.04M -14.09% 1.98M 6.51% 7.9M
Operating expense
32.09% 111.15M 42.61% 69.82M 126.17% 46.43M 28.38% 131.28M
Administration expense
10.63% 95.17M 2.15% 62.61M 12.30% 32.84M 5.95% 115.61M
Financial expense
-26.32% 48.33M -20.50% 33.37M -10.70% 17.71M 24.20% 84.03M
-Interest expense (Financial expense)
-22.01% 43.49M -16.21% 31.14M -12.35% 17.42M 6.44% 76.42M
-Interest Income (Financial expense)
11.47% 2.01M 29.33% 1.66M 79.18% 819.61K -58.27% 3.09M
Research and development
52.69% 68.47M 57.40% 44.94M 35.90% 19.58M -11.26% 56.5M
Credit Impairment Loss
-734.66% -10.86M -469.78% -7.1M -242.62% -6.66M 28.43% -8.92M
Asset Impairment Loss
-3,265.96% -6.94M -201.53% -1.87M -101.33% -358.89K -219.42% -22.02M
Other net revenue
-674.20% -15.63M -86.37% -7.4M -3.15% -7.51M -491.02% -32.15M
Fair value change income
29.79% -7.76M 52.87% -4.08M 64.47% -2.69M -526.76% -10.17M
Invest income
-82.12% 634.96K -133.61% -425.35K -74.11% 127.34K -21.62% 3.66M
-Including: Investment income associates
-- -- -- -- -- -- -97.06% 33.59K
Asset deal income
-- -67.72K -- -67.72K -- -- -- --
Other revenue
163.28% 9.36M 117.71% 6.14M 7.94% 2.08M -73.46% 5.31M
Operating profit
-251.14% -44.36M -146.38% -11.04M -90.29% 2.98M 7.94% 35.61M
Add:Non operating Income
-98.18% 127.66K -99.74% 18.53K -- 544.91 34,984.69% 7.02M
Less:Non operating expense
1,390.49% 11.88M 37,853.55% 11.88M 37.40% 29.03K 833.13% 35.17M
Total profit
-257.75% -56.11M -174.38% -22.91M -90.37% 2.95M -74.52% 7.45M
Less:Income tax cost
-66.49% 2.16M -54.34% 1.28M -80.41% 781.16K -59.16% 671.41K
Net profit
SL -58.27M SL -24.18M -91.86% 2.17M -75.44% 6.78M
Net profit from continuing operation
-299.99% -58.27M -186.35% -24.18M -91.86% 2.17M -75.44% 6.78M
Less:Minority Profit
-266.22% -1.39M 52.54% 1.25M 29.41% -163.13K 147.61% 783.26K
Net profit of parent company owners
-300.99% -56.88M -193.56% -25.43M -91.33% 2.33M -79.50% 6M
Earning per share
Basic earning per share
-300.60% -0.1011 -193.20% -0.0452 -91.48% 0.0041 -80.00% 0.0107
Diluted earning per share
-300.60% -0.1011 -193.20% -0.0452 -91.48% 0.0041 -80.00% 0.0107
Other composite income
-212.39% -138.62M -133.00% -69.09M -102.36% -4.64M 3.65% 199.43M
Other composite income of parent company owners
-217.74% -116.76M -133.00% -55.55M -102.36% -3.73M 3.65% 160.34M
Other composite income of minority owners
-190.44% -21.86M -133.00% -13.54M -102.36% -909.64K 3.65% 39.09M
Total composite income
-229.13% -196.89M -139.30% -93.27M -101.11% -2.47M -6.27% 206.21M
Total composite income of parent company owners
-236.22% -173.64M -141.42% -80.98M -100.76% -1.4M -9.57% 166.34M
Total composite income of minority owners
-192.97% -23.25M -129.36% -12.29M -102.80% -1.07M 10.55% 39.87M
Currency Unit
CNYCNYCNYCNY
Accounting Standards
CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions
------Unqualified opinion
Auditor
------Beijing Xinghua Accounting firm (Special General Partnership)

Q6, Q9, and FY are cumulative quarterly reports: Q6 is the interim report; Q9 is third quarter report; FY is the annual report.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%

Company Overview More
The company is approved by Henan Economic system Reform Commission (1998) No. 38, with Zhengzhou Zhongsheng Industrial Group Co., Ltd. as the main sponsor. Henan Zhiyi Investment and Development Co., Ltd., Zhengzhou Zhulin Xianzhu washing products Co., Ltd., Zhengzhou Zhulin Refractory Co., Ltd., Gongyi Zhulin Xinhua Packaging material Factory and other five enterprises jointly initiated and established the joint stock co., Ltd. With the approval of document No. 98 issued by CSRC [1999], the company issued 35 million public shares on August 13, 1999, with a total share capital of 136.14524 million yuan. The company's main business is drug manufacturing and drug R & D services, including pharmaceutical preparations, traditional Chinese medicine slices, drug R & D services and the circulation of pharmaceutical materials. The company's pharmaceutical preparation business is mainly oral preparation of traditional Chinese medicine, covering respiratory system, cardio-cerebrovascular, digestive system, nervous system and gynecological diseases. the main products include Shuanghuanglian oral liquid series, Shuanghuanglian mixture, Salvia miltiorrhiza oral liquid, Xiaoer Qingre Zhike oral liquid, children compound chicken inner gold chewable tablets, Huperzine A tablets and so on. Among them, Shuanghuanglian oral liquid (concentrated), Shuanghuanglian oral liquid (children's type), Shuanghuanglian mixture and children's compound chicken inner gold chewing tablets are the company's exclusive products. Enterprise honor: the all-China Federation of Industry and Commerce Pharmaceutical Chamber of Commerce awarded the company the honor of "Anti-epidemic Charity and Love", Henan High-tech Enterprises, "National High-tech industrialization demonstration Project", "excellent Enterprises in Zhengzhou" and so on.
CEO: --
Market: --
Listing Date: 11/05/1999
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist